Nasdaq: PRPO/Diagnostics & Research
Precipio, Inc.
New Haven, CT, United States
Company overview
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
This profile is for informational purposes only and is not investment advice. Company information may change after the verification date.